Company / EPS (Diluted)
Baxter International EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$5.23
FY2025
5-year range
-$4.83 / $5.23
FY2021-FY2025
Trend
+208.3%
vs FY2024
Sector context
#31 of 159
Health Care
What the data says
EPS (Diluted) changed +208% YoY in FY2025, a notable deviation from the 9-year average annual change of +38%.
Based on SEC 10-K filings.
5.23 in FY2025 with a 5-year CAGR of +13.1%. Top quartile in the Health Care sector.
Improved from $2.53 to $5.23 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +34.9%
- 5-Year CAGR
- +13.1%
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 159This company $5.23 Sector average $1.56
▼
+236.0% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 208.3% year-over-year.
- Ranks #31 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2018.
- Lowest eps (diluted) in the period was in FY2024.
Company context
Key Data Points
- Negative profit margin: -6.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.23 | +208.3% |
| FY2024 | -$4.83 | -290.9% |
| FY2023 | $2.53 | +18.8% |
| FY2022 | $2.13 | +10.4% |
| FY2021 | $1.93 | -31.8% |
| FY2020 | $2.83 | +162.0% |
| FY2019 | $1.08 | -88.0% |
| FY2018 | $9.01 | +411.9% |
| FY2017 | $1.76 | -61.4% |
| FY2016 | $4.56 | +24.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026